MBFW
HZNP

Morton Brown Family Wealth’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Morton Brown Family Wealth’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3
Closed – – 352
2022
Q2 		$0 Buy
+3
New +$284 ﹤0.01% 314

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morton Brown Family Wealth's HZNP Position: Q3 2022 in Review

Morton Brown Family Wealth sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 3 shares.

Morton Brown Family Wealth first reported a position in HZNP in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

  • Morton Brown Family Wealth reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Morton Brown Family Wealth sold 3 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022.
  • Morton Brown Family Wealth first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2022 and held it in 1 quarter.
  • Morton Brown Family Wealth's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $0 in Q2 2022.
  • 530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Morton Brown Family Wealth's 13F filing for Q3 2022, filed 31 Oct 2022.